16 November 2020: Articles
Avatrombopag Optimizes Response to Niraparib by Managing Thrombocytopenia Associated with Poly-ADP Ribose Polymerase (PARP) Inhibition in Ovarian Cancer and Breast Cancer: A Case Series
Unusual or unexpected effect of treatment
Nash Gabrail A* , Carrie Smith ADOI: 10.12659/AJCR.927008
Am J Case Rep 2020; 21:e927008
Figure 4. Case 3, platelet count, niraparib dose, and avatrombopag dose over time.